Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody
Publication
, Journal Article
Choi, BD; Gedeon, PC; Sanchez-Perez, L; Bigner, DD; Sampson, JH
Published in: OncoImmunology
December 1, 2013
Regulatory T cells (Tregs) play a central role in in tumor escape from immunosurveillance. We report that a bispecific T-cell engager (BiTE) targeting a mutated form of the epidermal growth factor receptor, i.e., EGFRvIII, potently redirects Tregs to kill glioblastoma through the granzyme-perforin pathway. © 2013 Landes Bioscience.
Duke Scholars
Published In
OncoImmunology
DOI
EISSN
2162-402X
ISSN
2162-4011
Publication Date
December 1, 2013
Volume
2
Issue
12
Start / End Page
1 / 2
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Choi, B. D., Gedeon, P. C., Sanchez-Perez, L., Bigner, D. D., & Sampson, J. H. (2013). Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody. OncoImmunology, 2(12), 1–2. https://doi.org/10.4161/onci.26757
Choi, B. D., P. C. Gedeon, L. Sanchez-Perez, D. D. Bigner, and J. H. Sampson. “Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody.” OncoImmunology 2, no. 12 (December 1, 2013): 1–2. https://doi.org/10.4161/onci.26757.
Choi BD, Gedeon PC, Sanchez-Perez L, Bigner DD, Sampson JH. Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody. OncoImmunology. 2013 Dec 1;2(12):1–2.
Choi, B. D., et al. “Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody.” OncoImmunology, vol. 2, no. 12, Dec. 2013, pp. 1–2. Scopus, doi:10.4161/onci.26757.
Choi BD, Gedeon PC, Sanchez-Perez L, Bigner DD, Sampson JH. Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody. OncoImmunology. 2013 Dec 1;2(12):1–2.
Published In
OncoImmunology
DOI
EISSN
2162-402X
ISSN
2162-4011
Publication Date
December 1, 2013
Volume
2
Issue
12
Start / End Page
1 / 2
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
- 1112 Oncology and Carcinogenesis
- 1107 Immunology